The observation that the insulinotropic actions of GLP-1 are reduced in type 2 diabetes mellitus (T2DM) led to the development of incretin-based therapies GLP-1 receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of hyperglycaemia in these patients
[DOI] [PubMed] [Google Scholar] 124.Kapitza C., Zdravkovic M., Hindsberger C., Flint A
B Older adults (aged 65 years) with diabetes should be considered a high-priority population for depression screening and treatment
What actually happens is a broader sympathomimetic activation that makes everything feel slightly heightened
Does Medicaid cover semaglutide
Baggio LL, Yusta B, Mulvihill EE, Cao X, Streutker CJ, Butany J, Cappola TP, Margulies KB, Drucker DJ